Status: Not yet recruiting
Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer
We plan to conduct a prospective, two-arm, open-label phase Ⅱ study to evaluate whether transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab significantly improves the efficacy and safety compared with systemic FOLFOX therapy plus/minus cetuximab/bevacizumab in elderly patients with advanced unresectable colorectal cancer.
Participants needed: 50
Trial details
Phase: Phase 2Age: 65+Biological sex: AllType: InterventionalSponsor: Junpeng WangUpdated: Oct 7, 2025
Eligibility criteria
Age ≥ 65 years, gender not restricted Pathologically confirmed advanced colorect...
Concomitant other malignant tumors Presence of gastrointestinal perforation Seve...